Delivery Order SPE2DB20D2001-SPE2DB25FPLVQ
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.46, is a delivery order for the supply of an Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of January 28, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,661.61, is for the delivery of Advair HFA 45-21 MCG inhalers. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $19,671.08 and is a delivery order that runs through August 12, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhaler 12GM. The contract is a Delivery Order with a Firm Fixed Price pricing type, a Ceiling Value of $3,467.28, and an Ultimate Completion Date of March 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This federal contract award, SPE2DB20D1100|SPE2DB24FC2C0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, and has a firm fixed price ceiling value of $18,564.59. The contract is a delivery order that has an ultimate completion date of June 11, 2024. This award is not associated with a set-aside...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award, valued at $4,920.42, is for the delivery of Advair HFA 230-21 MCG inhalers. The contract is a firm-fixed price Delivery Order with a completion date of February 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. This contract is part of a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Advair HFA 115-21 MCG inhalers. The contract has a ceiling value of $1,923.93 and is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract runs through October 2024 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $4,621.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler, a prescription medication, to support military healthcare programs. This is a firm fixed-price delivery order contract with a period of performance through January 2025. The contract was not set aside for any specific...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,270.22, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a critical pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with an ID of SPE2DB22D2108|SPE2DB25FU2WT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,765.23 Firm Fixed Price Delivery Order contract is for the supply of the Advair HFA 230-21 MCG Inhaler, a pharmaceutical product used for the treatment of respiratory conditions. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. The place of...